bf/NASDAQ:ADMA_icon.jpeg

COM:ADMABIOLOGICS

ADMA Biologics, Inc.

  • Stock

USD

Last Close

21.30

22/11 21:00

Market Cap

2.78B

Beta: -

Volume Today

2.10M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
3.07M
-
5.92M
92.84%
7.18M
21.34%
10.66M
48.53%
22.76M
113.49%
16.99M
25.37%
29.35M
72.79%
42.22M
43.85%
80.94M
91.72%
154.08M
90.36%
258.21M
67.59%
cost of revenue
2.02M
-
3.74M
84.95%
4.31M
15.21%
6.36M
47.53%
29.16M
358.50%
42.19M
44.68%
39.50M
6.38%
61.29M
55.15%
79.77M
30.15%
118.81M
48.95%
170.00M
43.08%
gross profit
1.04M
-
2.17M
108.13%
2.87M
31.89%
4.30M
50.04%
-6.40M
248.92%
-25.21M
293.66%
-10.16M
59.72%
-19.07M
87.80%
1.17M
106.15%
35.27M
2,905.68%
88.22M
150.16%
selling and marketing expenses
general and administrative expenses
4.37M
-
4.82M
10.50%
6.75M
39.85%
8.49M
25.92%
18.09M
112.99%
22.50M
24.37%
selling general and administrative expenses
4.37M
-
4.82M
10.50%
6.75M
39.85%
8.49M
25.92%
18.09M
112.99%
22.50M
24.37%
25.91M
15.14%
35.05M
35.28%
42.90M
22.38%
52.46M
22.29%
63.29M
20.64%
research and development expenses
9.30M
-
9.52M
2.30%
7.02M
26.28%
7.69M
9.58%
6.23M
18.97%
3.93M
36.98%
2.34M
40.30%
5.91M
152.02%
3.65M
38.28%
3.61M
0.89%
3.30M
8.68%
other expenses
82.50K
-
-74.36K
190.13%
4.62M
6,310.75%
4.50K
99.90%
-10.14K
325.62%
-127.12K
1,153.16%
3.01M
2,471.42%
4.89M
62.06%
13.00M
166.18%
18.56M
42.71%
-287K
101.55%
cost and expenses
18.11M
-
21.93M
21.12%
22.69M
3.45%
27.99M
23.36%
61.23M
118.73%
77.27M
26.21%
70.77M
8.41%
107.13M
51.38%
139.32M
30.04%
193.44M
38.85%
236.58M
22.30%
operating expenses
16.09M
-
18.19M
13.09%
18.38M
1.03%
21.63M
17.69%
32.06M
48.22%
35.08M
9.42%
31.27M
10.86%
45.84M
46.61%
59.55M
29.89%
74.63M
25.33%
66.59M
10.78%
interest expense
618.23K
-
1.29M
108.05%
1.84M
43.27%
2.24M
21.54%
3.29M
46.72%
5.52M
68.08%
8.99M
62.84%
11.99M
33.27%
13.06M
8.94%
19.28M
47.66%
25.03M
29.81%
ebitda
-14.74M
-
-16.08M
9.07%
-15.01M
6.67%
-16.81M
11.99%
-37.18M
121.25%
-56.77M
52.69%
-40.01M
29.54%
-64.04M
60.08%
-57.88M
9.63%
-39.24M
32.20%
29.96M
176.36%
operating income
-15.04M
-
-16.02M
6.49%
-15.51M
3.15%
-17.33M
11.71%
-39.31M
126.83%
-60.29M
53.37%
-41.42M
31.29%
-64.91M
56.71%
-58.37M
10.08%
-39.37M
32.56%
21.63M
154.95%
depreciation and amortization
210.63K
-
247.85K
17.67%
469.82K
89.56%
469.58K
0.05%
1.23M
162.93%
3.45M
179.13%
1.42M
58.84%
874.95K
38.31%
498.31K
43.05%
125.80K
74.76%
8.33M
6,523.37%
total other income expenses net
125.79K
-
-74.36K
159.11%
-651.24K
775.84%
4.50K
100.69%
-2.07M
46,046.37%
-127.12K
93.85%
-6.85M
5,292.49%
-10.83M
58.04%
-13.27M
22.52%
-26.54M
99.93%
-49.87M
87.92%
income before tax
-15.53M
-
-17.36M
11.83%
-17.97M
3.48%
-19.52M
8.60%
-43.76M
124.23%
-65.74M
50.24%
-48.28M
26.56%
-75.75M
56.90%
-71.65M
5.41%
-65.90M
8.02%
-28.24M
57.15%
income tax expense
484.81K
-
-551.72K
213.80%
2.46M
545.17%
2.18M
11.05%
4.45M
103.64%
5.45M
22.60%
8.77M
60.71%
11.86M
35.26%
12.81M
8.00%
19.28M
50.56%
net income
-15.53M
-
-16.81M
8.28%
-17.97M
6.88%
-19.52M
8.60%
-43.76M
124.23%
-65.74M
50.24%
-57.05M
13.23%
-87.61M
53.57%
-84.45M
3.60%
-85.18M
0.86%
-28.24M
66.85%
weighted average shs out
6.53M
-
9.29M
42.27%
10.41M
12.06%
12.15M
16.72%
22.90M
88.39%
45.19M
97.37%
54.35M
20.27%
86.15M
58.51%
139.58M
62.03%
197.87M
41.77%
223.98M
13.19%
weighted average shs out dil
6.53M
-
9.29M
42.27%
10.41M
12.06%
12.15M
16.72%
22.90M
88.39%
45.19M
97.37%
54.35M
20.27%
86.15M
58.51%
139.58M
62.03%
197.87M
41.77%
223.98M
13.19%
eps
-2.38
-
-1.81
23.95%
-1.73
4.42%
-1.61
6.94%
-1.91
18.63%
-1.45
24.08%
-1.05
27.59%
-1.02
2.86%
-0.61
40.20%
-0.43
29.51%
-0.13
69.77%
epsdiluted
-2.38
-
-1.81
23.95%
-1.73
4.42%
-1.61
6.94%
-1.91
18.63%
-1.45
24.08%
-1.05
27.59%
-1.02
2.86%
-0.61
40.20%
-0.43
29.51%
-0.13
69.77%

All numbers in USD (except ratios and percentages)